CTKB · Cytek BioSciences Inc
United States · RS rating 90 · As of 2026-10-14
| Price | 5.39 USD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 94 / 89 / 85 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 46 / 48 |
| Industry group (rank) | Medical-Research Eqp/Svc (31) |
| EPS growth Q/Q | +55.9% |
| Sales growth Q/Q | +18.8% |
| Distance from 52-week high | +11.4% |
| Market cap (USD) | $547.6M |